These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 25847735)

  • 1. [Is there a place for thrombin generation assay in routine clinical laboratory?].
    Lecut C; Peters P; Massion PB; Gothot A
    Ann Biol Clin (Paris); 2015; 73(2):137-49. PubMed ID: 25847735
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Thrombinography: towards a globalization of coagulation tests].
    Péters P; Gothot A
    Rev Med Liege; 2009 Apr; 64(4):199-203. PubMed ID: 19514539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acquired coagulation disorders: revisited using global coagulation/anticoagulation testing.
    Tripodi A; Chantarangkul V; Mannucci PM
    Br J Haematol; 2009 Oct; 147(1):77-82. PubMed ID: 19659548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thrombin Generation Assay and Its Application in the Clinical Laboratory.
    Tripodi A
    Clin Chem; 2016 May; 62(5):699-707. PubMed ID: 26955824
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical use of thrombin generation assays.
    Binder NB; Depasse F; Mueller J; Wissel T; Schwers S; Germer M; Hermes B; Turecek PL
    J Thromb Haemost; 2021 Dec; 19(12):2918-2929. PubMed ID: 34592058
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thrombin Generation Assays (TGAs).
    Salvagno GL; Berntorp E
    Methods Mol Biol; 2017; 1646():515-522. PubMed ID: 28804851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. From laboratory to clinical practice: Dabigatran effects on thrombin generation and coagulation in patient samples.
    Helin TA; Lemponen M; Hjemdahl P; Rönquist-Nii Y; Lassila R; Joutsi-Korhonen L
    Thromb Res; 2015 Jul; 136(1):154-60. PubMed ID: 25981140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A combined approach using global coagulation assays quickly differentiates coagulation disorders with prolonged aPTT and low levels of FVIII activity.
    Matsumoto T; Nogami K; Shima M
    Int J Hematol; 2017 Feb; 105(2):174-183. PubMed ID: 27730530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contributions of procoagulants and anticoagulants to the international normalized ratio and thrombin generation assay in patients treated with warfarin: potential role of protein Z as a powerful determinant of coagulation assays.
    Choi Q; Kim JE; Hyun J; Han KS; Kim HK
    Thromb Res; 2013 Jul; 132(1):e70-5. PubMed ID: 23769659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Global coagulation tests: their applicability for measuring direct factor Xa- and thrombin inhibition and reversal of anticoagulation by prothrombin complex concentrate.
    Dinkelaar J; Patiwael S; Harenberg J; Leyte A; Brinkman HJ
    Clin Chem Lab Med; 2014 Nov; 52(11):1615-23. PubMed ID: 24902009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is placental blood a reliable source for the evaluation of neonatal hemostasis at birth?
    Raffaeli G; Tripodi A; Manzoni F; Scalambrino E; Pesenti N; Amodeo I; Cavallaro G; Villamor E; Peyvandi F; Mosca F; Ghirardello S
    Transfusion; 2020 May; 60(5):1069-1077. PubMed ID: 32315090
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Laboratory investigations for bleeding disorders.
    Hayward CP; Moffat KA; Liu Y
    Semin Thromb Hemost; 2012 Oct; 38(7):742-52. PubMed ID: 23011792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Standardization and clinical utility of thrombin-generation assays.
    Berntorp E; Salvagno GL
    Semin Thromb Hemost; 2008 Oct; 34(7):670-82. PubMed ID: 19085768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coagulation Testing in the Core Laboratory.
    Winter WE; Flax SD; Harris NS
    Lab Med; 2017 Nov; 48(4):295-313. PubMed ID: 29126301
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Measuring direct thrombin inhibitors with routine and dedicated coagulation assays: which assay is helpful?
    Curvers J; van de Kerkhof D; Stroobants AK; van den Dool EJ; Scharnhorst V
    Am J Clin Pathol; 2012 Oct; 138(4):551-8. PubMed ID: 23010710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Laboratory measurements of the oral direct factor Xa inhibitor edoxaban: comparison of prothrombin time, activated partial thromboplastin time, and thrombin generation assay.
    Morishima Y; Kamisato C
    Am J Clin Pathol; 2015 Feb; 143(2):241-7. PubMed ID: 25596250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thrombin generation assays are versatile tools in blood coagulation analysis: A review of technical features, and applications from research to laboratory routine.
    Depasse F; Binder NB; Mueller J; Wissel T; Schwers S; Germer M; Hermes B; Turecek PL
    J Thromb Haemost; 2021 Dec; 19(12):2907-2917. PubMed ID: 34525255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of dabigatran on a large panel of routine or specific coagulation assays. Laboratory recommendations for monitoring of dabigatran etexilate.
    Douxfils J; Mullier F; Robert S; Chatelain C; Chatelain B; Dogné JM
    Thromb Haemost; 2012 May; 107(5):985-97. PubMed ID: 22438031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thrombin generation assay: the present and the future.
    Wu Y; Lu Y; Zhang J
    Blood Coagul Fibrinolysis; 2023 Jan; 34(1):1-7. PubMed ID: 36598375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New approaches for measuring coagulation.
    Barrowcliffe TW; Cattaneo M; Podda GM; Bucciarelli P; Lussana F; Lecchi A; Toh CH; Hemker HC; Béguin S; Ingerslev J; Sørensen B
    Haemophilia; 2006 Jul; 12 Suppl 3():76-81. PubMed ID: 16684000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.